Heat shock protein 90 is involved in regulation of hypoxia-driven proliferation of embryonic neural stem/progenitor cells

Cell Stress and Chaperones

Volumn 14, Issue 2, 2009, Pages 183-192

  Xiong, Lei ^a,b   Zhao, Tong ^b   Huang, Xin ^b   Liu, Zhao Hui ^b   Zhao, Hua ^b   Li, Ming Ming ^b   Wu, Li Ying ^b   Shu, Hong Bing ^a   Zhu, Ling Ling ^b   Fan, Ming ^a  

^a WUHAN UNIVERSITY   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Embryonic neural stem or progenitor cells; Geldanamycin; HIF 1 ; HSP90; Hypoxia

Indexed keywords

ERYTHROPOIETIN; GELDANAMYCIN; HEAT SHOCK PROTEIN 90; HYPOXIA INDUCIBLE FACTOR 1ALPHA; RADICICOL; VASCULOTROPIN; BENZOQUINONE DERIVATIVE; MACROCYCLIC LACTAM; MACROLIDE;

ANIMAL CELL; ARTICLE; CELL HYPOXIA; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; ANIMAL; CELL SURVIVAL; CYTOLOGY; DENSITOMETRY; DRUG EFFECT; GENE EXPRESSION REGULATION; METABOLISM; NERVE CELL; PROTEIN STABILITY; TIME; WISTAR RAT;

ANIMALS; BENZOQUINONES; CELL HYPOXIA; CELL PROLIFERATION; CELL SURVIVAL; DENSITOMETRY; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION; HSP90 HEAT-SHOCK PROTEINS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LACTAMS, MACROCYCLIC; MACROLIDES; NEURONS; PROTEIN STABILITY; RATS; RATS, WISTAR; TIME FACTORS;

EID: 64049112830     PISSN: 13558145     EISSN: 14661268     Source Type: Journal    
DOI: 10.1007/s12192-008-0071-z     Document Type: Article

References (44)

1. Acker T, Acker H (2004) Cellular oxygen sensing need in CNS function: physiological and pathological implications. J Exp Biol 207:3171-3188. doi:10.1242/jeb.01075 (Pubitemid 39275292)
2. Alqawi O, Moqhaddas M, Singh G (2006) Effects of geldanamycin on HIF-1alpha mediated angiogenesis and invasion in prostate cancer cells. Prostate Cancer Prostatic Dis 9:126-135. doi:10.1038/sj.pcan.4500852 (Pubitemid 43970961)
3. Bagatell R, Whitesell L (2004) Altered Hsp90 function in cancer: a unique therapeutic opportunity. Mol Cancer Ther 3:1021-1030 (Pubitemid 39199597)
4. Bisht KS, Bradbury CM, Mattson D et al (2003) Geldanamycin and 17-allylamino-17-demethoxygeldanamycin potentiate the in vitro and in vivo radiation response of cervical tumor cells via the heat shock protein 90-mediated intracellular signaling and cytotoxicity. Cancer Res 63:8984-8995 (Pubitemid 38064080)
5. Bruick RK (2003) Oxygen sensing in the hypoxic response pathway: regulation of the hypoxia-inducible transcription factor. Genes Dev 17:2614-2623. doi:10.1101/gad.1145503
6. Calderwood SK, Khaleque MA, Sawyer DB, Ciocca DR (2006) Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci 31:164-172. doi:10.1016/j.tibs.2006.01.006 (Pubitemid 43361923)
7. Carmeliet P, Dor Y, Herbert JM et al (1998) Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394:485-490. doi:10.1038/28867 (Pubitemid 28373960)
8. de Carcer G (2004) Heat shock protein 90 regulates the metaphase-anaphase transition in a polo-like kinase-dependent manner. Cancer Res 64:5106-5112. doi:10.1158/0008-5472.CAN-03-2214
9. Goetz MP, Toft DO, Ames MM, Erlichman C (2003) The Hsp90 chaperone complex as a novel target for cancer therapy. Ann Oncol 14:1169-1176. doi:10.1093/annonc/mdg316 (Pubitemid 37039035)
10. Gradin K, McGuire J, Wenger RH, Kvietikova I, Whitelaw ML, Toftgard R, Tora L, Gassmann M, Poellinger L (1996) Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor. Mol Cell Biol 16:5221-5231 (Pubitemid 26315042)
11. Han JY, Oh SH, Morgillo F, Myers JN, Kim E, Hong WK, Lee HY (2005) Hypoxia-inducible factor 1alpha and antiangiogenic activity of farnesyltransferase inhibitor SCH66336 in human aerodigestive tract cancer. J Natl Cancer Inst 97:1272-1286 (Pubitemid 41535368)
12. Hostein I, Robertson D, DiStefano F, Workman P, Clarke PA (2001) Inhibition of signal transduction by the Hsp90 inhibitor 17-allylamino-17- demethoxygeldanamycin results in cytostasis and apoptosis. Cancer Res 61:4003-4009 (Pubitemid 32720963)
13. Hur E, Kim HH, Choi SM, Kim JH, Yim S, Kwon HJ, Choi Y, Kim DK, Lee MO, Park H (2002) Reduction of hypoxia-induced transcription through the repression of hypoxia-inducible factor-1alpha/aryl hydrocarbon receptor nuclear translocator DNA binding by the 90-kDa heat-shock protein inhibitor radicicol. Mol Pharmacol 62:975-982. doi:10.1124/mol.62.5.975 (Pubitemid 35222488)
14. Isaacs JS, Jung YJ, Mimnaugh EG, Martinez A, Cuttitta F, Neckers LM (2002) Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway. J Biol Chem 277:29936-29944. doi:10.1074/jbc.M204733200
15. 2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 12:149-162. doi:10.1101/gad.12.2.149
16. Janin YL (2005) Heat shock protein 90 inhibitors. A text book example of medicinal chemistry? J Med Chem 48:7503-7512. doi:10.1021/jm050759r
17. Kallio PJ, Wilson WJ, O'Brien S, Makino Y, Poellinger L (1999) Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J Biol Chem 274:6519-6525 (Pubitemid 29111068)
18. Katschinski DM, Le L, Heinrich D, Wagner KF, Hofer T, Schindler SG, Wenger RH (2002) Heat induction of the unphosphorylated form of hypoxia-inducible factor-1alpha is dependent on heat shock protein-90 activity. J Biol Chem 277:9262-9267. doi:10.1074/jbc.M110377200 (Pubitemid 34953008)
19. Katschinski DM, Le L, Schindler SG, Thomas T, Voss AK, Wenger RH (2004) Interaction of the PAS B domain with HSP90 accelerates hypoxia-inducible factor-1alpha stabilization. Cell Physiol Biochem 14:351-360. doi:10.1159/000080345 (Pubitemid 39179204)
20. Kong X, Alvarez-Castelao B, Lin Z, Castǎo JG, Caro J (2007) Constitutive/hypoxic degradation of HIF-alpha proteins by the proteasome is independent of von Hippel Lindau protein ubiquitylation and the transactivation activity of the protein. J Biol Chem 282:15498-15505 doi:10.1074/jbc.M700704200 (Pubitemid 47093272)
21. Krishan A (1975) Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J Cell Biol 66:188-193. doi:10.1083/jcb.66. 1.188
22. Lang SA, Klein D, Moser C et al (2007) Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo. Mol Cancer Ther 6:1123-1132. doi:10.1158/1535-7163. MCT-06-0628 (Pubitemid 46554583)
23. Liu YV, Baek JH, Zhang H, Diez R, Cole RN, Semenza GL (2007) RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha. Mol Cell 25:207-217. doi:10.1016/j.molcel.2007.01.001 (Pubitemid 46109612)
24. Mabjeesh NJ, Post DE, Willard MT, Kaur B, Van Meir EG, Simons JW, Zhong H (2002) Geldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteosome pathway in prostate cancer cells. Cancer Res 62:2478-2486 (Pubitemid 34462721)
25. Marxsen JH, Stengel P, Doege K, Heikkinen P, Jokilehto T, Wagner T, Jelkmann W, Jaakkola P, Metzen E (2004) Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases. Biochem J 381:761-767 doi:10.1042/BJ20040620 (Pubitemid 39120486)
26. Maxwell PH, Wiesener MS, Chang GW et al. (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271-275.
27. Minet E, Mottet D, Michel G, Roland I, Raes M, Remacle J, Michiels C (1999) Hypoxia-induced activation of HIF-1: role of HIF-1-Hsp90 interaction. FEBS Lett 460:251-256. doi:10.1016/S0014-5793(99)01359-9 (Pubitemid 29495950)
28. Morrison SJ, Csete M, Groves AK, Melega W, Wold B, Anderson DJ (2000) Culture in reduced levels of oxygen promotes clonogenic sympathoadrenal differenetation by isolated neural crest stem cells. J Neurosci 20:7370-7376 (Pubitemid 30747433)
29. Munster PN, Srethapakdi M, Moasser MM, Rosen N (2001) Inhibition of heat shock protein 90 function by ansamycins causes the morphological and functional differentiation of breast cancer cells. Cancer Res 61:2945-2952 (Pubitemid 32691939)
30. Park KI, Hack MA, Ourednik J et al (2006) Acute injury directs the migration, proliferation, and differentiation of solid organ stem cells: evidence from the effect of hypoxia-ischemia in the CNS on clonal "reporter" neural stem cells. Exp Neurol 199:156-178. doi:10.1016/j.expneurol.2006.03.016
31. Schwock J, Geddie WR, Hedley DW (2005) Analysis of hypoxia-inducible factor-1alpha accumulation and cell cycle in geldanamycin-treated human cervical carcinoma cells by laser scanning cytometry. Cytometry A 68:59-70. doi:10.1002/cyto.a.20192 (Pubitemid 41705199)
32. Semenza GL (2000) Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol 35:71-103. doi:10.1080/ 10409230091169186
33. Shi YH, Fang WG (2004) Hypoxia-inducible factor-1 in tumour angiogenesis. World J Gastroenterol 10:1082-1087
34. Solit DB, Basso AD, Olshen AB, Scher HI, Rosen N (2003) Inhibition of heat shock protein 90 function down-regulates Akt kinase and sensitizes tumors to Taxol. Cancer Res 63:2139-2144
35. Sõti C, Nagy E, Giricz Z, Vígh L, Csermely P, Ferdinandy P (2005) Heat shock proteins as emerging therapeutic targets. Br J Pharmacol 146:769-780. doi:10.1038/sj.bjp.0706396 (Pubitemid 41622243)
36. Sreedhar AS, Mihály K, Pató B et al (2003) Hsp90 inhibition accelerates cell lysis. Anti-Hsp90 ribozyme reveals a complex mechanism of Hsp90 inhibitors involving both superoxide- and Hsp90-dependent events. J Biol Chem 278:35231-35240. doi:10.1074/jbc.M301371200 (Pubitemid 37102289)
37. Sreedhar AS, Kalmár E, Csermely P, Shen YF (2004) Hsp90 isoforms: functions, expression and clinical importance. FEBS Lett 562:11-15. doi:10.1016/S0014-5793(04)00229-7 (Pubitemid 38388440)
38. Storch A, Paul G, Csete M, Boehm BO, Carvey PM, Kupsch A, Schwarz J (2001) Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells. Exp Neurol 170:317-325. doi:10.1006/exnr.2001.7706 (Pubitemid 32758685)
39. Studer L, Csete M, Lee SH, Kabbane N, Walikonis J, Wold B, McKay R (2000) Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J Neurosci 20:7377-7383 (Pubitemid 30747434)
40. Vaupel P (2004) The role of hypoxia-induced factors in tumor progression. Oncologist 5:10-17. doi:10.1634/theoncologist.9-90005-10 (Pubitemid 39658341)
41. Wiener CM, Booth G, Semenza GL (1996) In vivo expression of mRNAs encoding hypoxia-inducible factor 1. Biochem Biophys Res Commun 225:485-488. doi:10.1006/bbrc.1996.1199
42. Zhang CP, Zhu LL, Zhao T, Zhao H, Huang X, Ma X, Wang H, Fan M (2007) Characteristics of neural stem cells expanded in lowered oxygen and the potential role of hypoxia-inducible factor-1Alpha. Neurosignals 15:259-265. doi:10.1159/000103385 (Pubitemid 47264249)
43. Zhao T, Zhang CP, Liu ZH et al (2008) Hypoxia-driven proliferation of embryonic neural stem/progenitor cells - role of hypoxia-inducible transcription factor-1alpha. FEBS J 275:1824-1834. doi:10.1111/j.1742-4658.2008.06340.x
44. Zhu LL, Wu LY, Yew DT, Fan M (2005) Effects of hypoxia on the proliferation and differentiation of NSCs. Mol Neurobiol 31:231-242 doi:10.1385/MN:31:1-3:231